The Leukemia & Lymphoma Society (LLS) is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. Founded in 1949, LLS is relentless in the pursuit of its mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.
The need is critical. An estimated 1,185,053 people in the United States are living with, or are in remission from a blood cancer. Approximately every 3 minutes, someone new is diagnosed with a blood cancer. Every 9 minutes, someone passes away. Though we have made strides in achieving our mission, we won’t stop until the cure rate for all blood cancers reaches 100%.
Research: The Leukemia & Lymphoma Society funds lifesaving blood cancer research. Of 67 drugs newly FDA-approved as cancer treatments in years 2000-2012, almost half (28/67) were approved to treat one or more blood cancers and LLS helped advance all of them.
First Connection, a peer support program which brings together survivors with newly diagnosed patients, made 141 connections. The NYC chapter currently works with 94 active First Connection/Ambassador volunteers, including 7 Spanish-speaking volunteers.
In 2011, advocates helped pass the Oral Chemotherapy Parity Bill in New York State, which mandates that insurance companies cover the cost of oral chemotherapy at the same rate as intravenous chemotherapy. LLS advocates have played an integral part in getting this bill passed in both New York, as well as in 23 other states.
As a nonprofit organization, LLS relies on the generosity of individuals, corporations and foundations. 75% of our total expenses support cancer research, education, advocacy and patient services. In addition to Man & Woman of the Year, major annual fundraising campaigns include Team In Training, Light The Night Walk, and School & Youth Programs.
- Since 1949, LLS has invested more than $1 billion to advance cancer therapies and save lives, including $75 million in research this past fiscal year alone.
- In 2015, LLS invested nearly $67.2 million in over 277 research projects including $33 million to 53 research projects in NYC.
- 18,000 patients and families were able to afford drug co-pays and health insurance premiums essential to their care by enrolling in LLS's Co-Pay Assistance Program ($44 million). In NYC, 487 pediatric and adult blood cancer patients received $48,700 in patient aid (322 of the patients had never applied for or received aid from LLS before).
- 30,000 people battling their cancers received assistance from LLS to help pay for their transportation, lodging or other treatment-related expenses through LLS's Patient Financial Aid Program ($3 million).